NivolumabBullous pemphigoid: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1698卷 / 1期

关键词：

D O I：

10.1007/s40278-018-45202-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：258 / 258

相关论文

共 50 条

[41] Sitagliptin/vildagliptin/metforminBullous pemphigoid: 3 case reports
Reactions Weekly, 2013, 1448 (1) : 28 - 28
[42] Penpulimab/sintilimab/toripalimabBullous pemphigoid: 3 case reports
Reactions Weekly, 2022, 1918 (1) : 413 - 414
[43] Nivolumab/pembrolizumabBullous pemphigoid and bullous eruption: 3 case reports
Reactions Weekly, 2017, 1673 (1) : 282 - 282
[44] VildagliptinBullous pemphigoid: 2 case reports
Reactions Weekly, 2012, 1394 (1) : 41 - 41
[45] LinagliptinBullous pemphigoid: 2 case reports
Reactions Weekly, 2016, 1591 (1) : 115 - 115
[46] AntihyperglycaemicsBullous pemphigoid: 9 case reports
Reactions Weekly, 2018, 1694 (1) : 34 - 34
[47] LinagliptinBullous pemphigoid: 2 case reports
Reactions Weekly, 2021, 1872 (1) : 286 - 286
[48] AntihyperglycaemicsBullous pemphigoid: 12 case reports
Reactions Weekly, 2018, 1710 (1) : 36 - 36
[49] TozinameranBullous pemphigoid: 2 case reports
Reactions Weekly, 2022, 1913 (1) : 406 - 406
[50] NemolizumabBullous pemphigoid: 2 case reports
Reactions Weekly, 2024, 2029 (1) : 507 - 507

← 1 2 3 4 5 →